| Myofibroblasts in murine cutaneous fibrosis originate from adiponectin‐positive intradermal progenitors RG Marangoni, BD Korman, J Wei, TA Wood, LV Graham, ML Whitfield, ... Arthritis & rheumatology 67 (4), 1062-1073, 2015 | 323 | 2015 |
| Endotrophin triggers adipose tissue fibrosis and metabolic dysfunction K Sun, J Park, OT Gupta, WL Holland, P Auerbach, N Zhang, ... Nature communications 5 (1), 3485, 2014 | 318 | 2014 |
| Survival, causes of death, and prognostic factors in systemic sclerosis: analysis of 947 Brazilian patients PD Sampaio-Barros, AB Bortoluzzo, RG Marangoni, LF Rocha, ... The Journal of rheumatology 39 (10), 1971-1978, 2012 | 122 | 2012 |
| The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy F Fang, L Liu, Y Yang, Z Tamaki, J Wei, RG Marangoni, S Bhattacharyya, ... Arthritis research & therapy 14, 1-13, 2012 | 114 | 2012 |
| The histone deacetylase sirtuin 1 is reduced in systemic sclerosis and abrogates fibrotic responses by targeting transforming growth factor β signaling J Wei, AK Ghosh, H Chu, F Fang, ME Hinchcliff, J Wang, RG Marangoni, ... Arthritis & rheumatology 67 (5), 1323-1334, 2015 | 93 | 2015 |
| Phenotypes determined by cluster analysis and their survival in the prospective European scleroderma trials and research cohort of patients with systemic sclerosis V Sobanski, J Giovannelli, Y Allanore, G Riemekasten, P Airò, S Vettori, ... Arthritis & rheumatology 71 (9), 1553-1570, 2019 | 92 | 2019 |
| Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target RG Marangoni, Y Masui, F Fang, B Korman, G Lord, J Lee, K Lakota, ... Scientific reports 7 (1), 4397, 2017 | 77 | 2017 |
| Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease V Martyanov, GHJ Kim, W Hayes, S Du, BJ Ganguly, O Sy, SK Lee, ... PLoS One 12 (11), e0187580, 2017 | 72 | 2017 |
| The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib W Wang, S Bhattacharyya, RG Marangoni, M Carns, K Dennis-Aren, ... Journal of Scleroderma and Related Disorders 5 (1), 40-50, 2020 | 65 | 2020 |
| Brazilian lyme-like disease or Baggio-Yoshinari syndrome: exotic and emerging Brazilian tick-borne zoonosis NH Yoshinari, E Mantovani, VLN Bonoldi, RG Marangoni, G Gauditano Revista da Associação Médica Brasileira 56, 363-369, 2010 | 63 | 2010 |
| Animal models of scleroderma: recent progress RG Marangoni, J Varga, WG Tourtellotte Current opinion in rheumatology 28 (6), 561-570, 2016 | 54 | 2016 |
| Toll‐like receptor 9 signaling is augmented in systemic sclerosis and elicits transforming growth factor β–dependent fibroblast activation F Fang, RG Marangoni, X Zhou, Y Yang, B Ye, A Shangguang, W Qin, ... Arthritis & rheumatology 68 (8), 1989-2002, 2016 | 54 | 2016 |
| Systemic sclerosis sine scleroderma: distinct features in a large Brazilian cohort RG Marangoni, LF Rocha, APT Del Rio, NH Yoshinari, JF Marques-Neto, ... Rheumatology 52 (8), 1520-1524, 2013 | 51 | 2013 |
| Doença de lyme-símile brasileira ou síndrome baggioyoshinari: zoonose exótica e emergente transmitida por carrapatos NH Yoshinari, E Mantovani, VLN Bonoldi, RG Marangoni, G Gauditano Revista da Associação Médica Brasileira 56, 363-369, 2010 | 51 | 2010 |
| Amplification of the flgE gene provides evidence for the existence of a Brazilian borreliosis E Mantovani, RG Marangoni, G Gauditano, VLN Bonoldi, NH Yoshinari Revista do Instituto de Medicina Tropical de São Paulo 54, 153-158, 2012 | 48 | 2012 |
| Chronic recurrent multifocal osteomyelitis primarily affecting the spine treated with anti-TNF therapy RG Marangoni, ASR Halpern Spine 35 (7), E253-E256, 2010 | 46 | 2010 |
| Dermal white adipose tissue implicated in SSc pathogenesis J Varga, RG Marangoni Nature Reviews Rheumatology 13 (2), 71-72, 2017 | 45 | 2017 |
| Decreased high-density lipoprotein cholesterol levels in polyarticular juvenile idiopathic arthritis RG Marangoni, AL Hayata, EF Borba, PM Azevedo, E Bonfa, ... Clinics 66 (9), 1549-1552, 2011 | 44 | 2011 |
| The roles of dermal white adipose tissue loss in scleroderma skin fibrosis RG Marangoni, TT Lu Current opinion in rheumatology 29 (6), 585-590, 2017 | 38 | 2017 |
| Targeting CD38-dependent NAD+ metabolism to mitigate multiple organ fibrosis B Shi, W Wang, B Korman, L Kai, Q Wang, J Wei, S Bale, RG Marangoni, ... Iscience 24 (1), 2021 | 36 | 2021 |
